Citations

Citations to this article as recorded by  

• Histological assessment of extensive or unresectable central giant cell granulomas treated with denosumab: a case series
  Vinod Patel, Mahesh Kumar, Andrew Schache, Keith D. Hunter, Barbara Carey, Simon N. Rogers, Mustansir Alibhai, Selvam Thavaraj
  Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2025; 139(4): 439.     CrossRef
• Tumor de células gigantes óseo en arco costal, tratado con denosumab. Reporte de un caso
  Paula Serret Miralles, Ruth Orellana Fernández, Tamara Parra Parente, Rosa Belén García-Chamón Brígido, Rubén Carrera Salas
  Revista Española de Patología.2023; 56(2): 119.     CrossRef
• Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
  Anvesh Kamble, Monalisa Hui, K. Nageshwara Rao, N. Ramakrishna, P. Chandrasekhar, Shantveer G. Uppin, G. Sadashivudu
  Indian Journal of Medical and Paediatric Oncology.2021; 42(04): 325.     CrossRef
• Integration of denosumab therapy in the management of giant cell tumors of bone
  Daniel T. Miles, Ryan T. Voskuil, Wood Dale, Joel L. Mayerson, Thomas J. Scharschmidt
  Journal of Orthopaedics.2020; 22: 38.     CrossRef
• Radiological findings of denosumab treatment for giant cell tumours of bone
  Kirsten van Langevelde, Catherine L. McCarthy
  Skeletal Radiology.2020; 49(9): 1345.     CrossRef
• Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis
  Josef Yayan
  Cancer Control.2020;[Epub]     CrossRef